Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilary Shmeeda

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Journal of Drug Targeting|May 18, 2016
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancerHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.
Advanced Drug Delivery Reviews|August 11, 2020
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedsideAlberto Gabizon, Hilary Shmeeda, Esther Tahover, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2010
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cellsHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2022
Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumorsShira Dorot, James Tankel, Victoria Doviner, et al.
Cancer Medicine|July 15, 2015
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patientsTalia Golan, Tal Grenader, Patricia Ohana, et al.
International Journal of Nanomedicine|December 13, 2018
Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenograftsEsben Christensen, Jonas R Henriksen, Jesper T Jørgensen, et al.
Nanotheranostics|September 15, 2022
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma modelMd Rakibul Islam, Jalpa Patel, Patricia Ines Back, et al.
Pharmaceutics|November 25, 2023
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated LiposomesAlberto Gabizon, Hilary Shmeeda, Benjamin Draper, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2017
Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronateRobin Rajan, Manoj K Sabnani, Vikram Mavinkurve, et al.
Biomolecules|September 28, 2023
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma ModelMd Rakibul Islam, Jalpa Patel, Patricia Ines Back, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Journal of Drug Targeting|May 18, 2016
Coencapsulation of alendronate and doxorubicin in pegylated liposomes: a novel formulation for chemoimmunotherapy of cancerHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.
Advanced Drug Delivery Reviews|August 11, 2020
Development of Promitil®, a lipidic prodrug of mitomycin c in PEGylated liposomes: From bench to bedsideAlberto Gabizon, Hilary Shmeeda, Esther Tahover, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|May 14, 2010
Delivery of zoledronic acid encapsulated in folate-targeted liposome results in potent in vitro cytotoxic activity on tumor cellsHilary Shmeeda, Yasmine Amitay, Jenny Gorin, et al.
Cancer Chemotherapy and Pharmacology|July 8, 2022
Ex-vivo activation of a liposomal prodrug of mitomycin C by human tumorsShira Dorot, James Tankel, Victoria Doviner, et al.
Cancer Medicine|July 15, 2015
Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patientsTalia Golan, Tal Grenader, Patricia Ohana, et al.
International Journal of Nanomedicine|December 13, 2018
Folate receptor targeting of radiolabeled liposomes reduces intratumoral liposome accumulation in human KB carcinoma xenograftsEsben Christensen, Jonas R Henriksen, Jesper T Jørgensen, et al.
Nanotheranostics|September 15, 2022
Comparative effects of free doxorubicin, liposome encapsulated doxorubicin and liposome co-encapsulated alendronate and doxorubicin (PLAD) on the tumor immunologic milieu in a mouse fibrosarcoma modelMd Rakibul Islam, Jalpa Patel, Patricia Ines Back, et al.
Pharmaceutics|November 25, 2023
Harnessing Nanomedicine to Potentiate the Chemo-Immunotherapeutic Effects of Doxorubicin and Alendronate Co-Encapsulated in Pegylated LiposomesAlberto Gabizon, Hilary Shmeeda, Benjamin Draper, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 27, 2017
Liposome-induced immunosuppression and tumor growth is mediated by macrophages and mitigated by liposome-encapsulated alendronateRobin Rajan, Manoj K Sabnani, Vikram Mavinkurve, et al.
Biomolecules|September 28, 2023
Pegylated Liposomal Alendronate Biodistribution, Immune Modulation, and Tumor Growth Inhibition in a Murine Melanoma ModelMd Rakibul Islam, Jalpa Patel, Patricia Ines Back, et al.
Pageof 4